Legal & General Group PLC Acelrx Pharmaceuticals Inc Transaction History

Legal & General Group PLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$1.03 - $1.7 $9,534 - $15,736	-9,257 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$1.25 - $2.77 $1,455 - $3,224	1,164 Added 14.38%	9,257 $16,000
Q3 2020 Nov 13, 2020	SELL	$1.01 - $1.81 $2,814 - $5,044	-2,787 Reduced 25.62%	8,093 $11,000
Q1 2020 May 14, 2020	SELL	$0.76 - $2.07 $2,400 - $6,537	-3,158 Reduced 22.5%	10,880 $14,000
Q4 2019 Feb 13, 2020	BUY	$1.66 - $2.4 $1,646 - $2,380	992 Added 7.6%	14,038 $30,000
Q2 2019 Aug 14, 2019	BUY	$2.1 - $3.93 $27,396 - $51,270	13,046 New	13,046 $28,000

Ticker ACRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 7,366,600
Market Cap $8.32M
Description
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed ...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.